The neurodevelopmental and facial phenotype in individuals with a TRIP12 variant.
Journal
European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
07
07
2022
accepted:
27
01
2023
revised:
22
11
2022
pmc-release:
01
04
2024
medline:
28
4
2023
pubmed:
7
2
2023
entrez:
6
2
2023
Statut:
ppublish
Résumé
Haploinsufficiency of TRIP12 causes a neurodevelopmental disorder characterized by intellectual disability associated with epilepsy, autism spectrum disorder and dysmorphic features, also named Clark-Baraitser syndrome. Only a limited number of cases have been reported to date. We aimed to further delineate the TRIP12-associated phenotype and objectify characteristic facial traits through GestaltMatcher image analysis based on deep-learning algorithms in order to establish a TRIP12 gestalt. 38 individuals between 3 and 66 years (F = 20, M = 18) - 1 previously published and 37 novel individuals - were recruited through an ERN ITHACA call for collaboration. 35 TRIP12 variants were identified, including frameshift (n = 15) and nonsense (n = 6) variants, as well as missense (n = 5) and splice (n = 3) variants, intragenic deletions (n = 4) and two multigene deletions disrupting TRIP12. Though variable in severity, global developmental delay was noted in all individuals, with language deficit most pronounced. About half showed autistic features and susceptibility to obesity seemed inherent to this disorder. A more severe expression was noted in individuals with a missense variant. Facial analysis showed a clear gestalt including deep-set eyes with narrow palpebral fissures and fullness of the upper eyelids, downturned corners of the mouth and large, often low-set ears with prominent earlobes. We report the largest cohort to date of individuals with TRIP12 variants, further delineating the associated phenotype and introducing a facial gestalt. These findings will improve future counseling and patient guidance.
Identifiants
pubmed: 36747006
doi: 10.1038/s41431-023-01307-x
pii: 10.1038/s41431-023-01307-x
pmc: PMC10133310
doi:
Substances chimiques
TRIP12 protein, human
EC 2.3.2.26
Carrier Proteins
0
Ubiquitin-Protein Ligases
EC 2.3.2.27
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
461-468Subventions
Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States
Informations de copyright
© 2023. The Author(s), under exclusive licence to European Society of Human Genetics.
Références
Am J Hum Genet. 2009 Apr;84(4):524-33
pubmed: 19344873
Am J Med Genet A. 2020 Jul;182(7):1801-1806
pubmed: 32424948
Nat Genet. 2022 Mar;54(3):349-357
pubmed: 35145301
Nucleic Acids Res. 1987 Sep 11;15(17):7155-74
pubmed: 3658675
Am J Med Genet. 1987 Jan;26(1):13-5
pubmed: 3812552
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
PLoS One. 2011;6(10):e25871
pubmed: 22028794
Hum Genet. 2017 Feb;136(2):179-192
pubmed: 27848077
Nature. 2014 Nov 13;515(7526):216-21
pubmed: 25363768
Am J Med Genet A. 2020 Mar;182(3):595-596
pubmed: 31814248
Nat Commun. 2014 Nov 24;5:5595
pubmed: 25418537
J Comput Biol. 2004;11(2-3):377-94
pubmed: 15285897
Hum Genet. 2017 Apr;136(4):377-386
pubmed: 28251352
J Clin Endocrinol Metab. 2017 Mar 01;102(3):709-757
pubmed: 28359099
Front Genet. 2018 Feb 14;9:29
pubmed: 29491882
Int J Mol Sci. 2020 Nov 12;21(22):
pubmed: 33198194
J Comput Biol. 1997 Fall;4(3):311-23
pubmed: 9278062
Int J Mol Sci. 2022 Nov 08;23(22):
pubmed: 36430143
Nat Neurosci. 2016 Sep;19(9):1194-6
pubmed: 27479843